- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
OneSource reports strong Q1FY27 results: Revenue ₹449.0 Cr (+37% YoY), EBITDA ₹123.3 Cr (+39% YoY), PAT ₹63.7 Cr (+72% YoY). Growth driven by semaglutide launch & new client wins. Second cartridge line commercializing Q2; biologics pipeline growing. FY28 guidance of $400M organic revenue reaffirmed.